Soriano, V, et al.
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS
2007; 21: 1073–1089.
Maier, I, Wu, GY. Hepatitis C and HIV co-infection: a review. World Journal of Gastroenterology
2002; 8: 577–579.
Subramanian, A, et al.
MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology
2010; 138: 159–164.
Operskalski, EA, Kovacs, A. HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies. Current HIV/AIDS Reports
2011; 8: 12–22.
Aceijas, C, Rhodes, T. Global estimates of prevalence of HCV infection among injecting drug users. International Journal of Drug Policy. 2007; 18: 352–358.
Alter, MJ. Epidemiology of viral hepatitis and HIV co-infection. Journal of Hepatology
2006; 44: S6–9.
Mendes-Corrêa, MC, Barone, AA, Guastini, C. Hepatitis C virus seroprevalence and risk factors among patients with HIV infection. Revista do Instituto de Medicina Tropical de São Paulo
2001; 43: 15–19.
Pereira, GA, et al.
Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil. Journal of Medical Virology
2006; 78: 719–723.
Pavan, MH, et al.
Viral hepatitis in patients infected with human immunodeficiency virus. Brazilian Journal of Infectious Diseases
2003; 7: 253–261.
Backus, LI, Boothroyd, D, Deyton, LR. HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations. AIDS
2005; 19: S13–19.
Wolff, FH, et al.
Risk factors for hepatitis C virus infection in individuals infected with the HIV. Digestive and Liver Disease
2008: 40: 460–467.
Sulkowski, MS. Hepatitis C virus-human immunodeficiency virus coinfection. Liver International
2012; 32: 129–134.
Howe, CJ, et al.
Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City. Drug and Alcohol Dependence
2005; 79: 389–395.
Mendoza-Sassi, RA, Béria, JU. Prevalence of alcohol use disorders and associated factors: a population-based study using AUDIT in southern Brazil. Addiction
2003; 98: 799–804.
Martell, M, et al.
High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. Journal of Clinical Microbiology
1999; 37: 327–332.
Krug, LP, et al.
Hepatitis C virus genotypes in Southern Brazil. Brazilian Journal of Medical and Biological Research
1996; 29: 1629–1632.
Barros, AJ, Hirakata, VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Medical Research Methodology
2003; 3: 21.
Ministry of Health: Brazil. Epidemiological bulletin – AIDS and STD, 2010. Brasília, DF, Brazil, 2010, 52 pp.
Wolff, FH, et al.
Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates. PLoS One
2010; 5: e10494.
Segurado, AC, et al.
Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors. AIDS Patient Care and STDs
2004; 18: 135–143.
Bollepalli, S, et al.
Prevalence of risk factors for hepatitis C virus in HIV-infected and HIV/hepatitis C virus-coinfected patients. Sexually Transmitted Diseases
2007; 34: 367–370.
Wong, T, Lee, SS. Hepatitis C: a review for primary care physicians. Canadian Medical Association Journal
2006; 174: 649–659.
Kucirka, LM, et al.
Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis. American Journal of Transplantation
2011; 11: 1188–1200.
Nurutdinova, D, et al.
Risk factors associated with Hepatitis C among female substance users enrolled in community-based HIV prevention studies. BMC Research Notes
2011; 4: 126.
Van den Hoek, JA, et al.
Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. Journal of Infectious Diseases
1990; 162: 823–826.
Hagan, H, et al.
Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities. Journal of Infectious Diseases
2010; 201: 378–385.
Alter, MJ, et al.
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New England Journal of Medicine
1999; 341: 556–562.
Navarro, RM, et al.
Clinical laboratory assessment of hepatitis C and HIV coinfected patients according to the antiretroviral therapy received. Revista do Instituto de Medicina Tropical de São Paulo
2005; 47: 13–17.
Neblett, RC, et al.
Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival. Journal of Women's Health
2011; 20: 279–286.
Stein, M, et al.
Alcohol use and sexual risk behavior among human immunodeficiency virus-positive persons. Alcoholism, Clinical and Experimental Research
2005; 29: 837–843.
Bonacini, M. Alcohol use among patients with HIV infection. Annals of Hepatology
2011; 10: 502–507.
Baum, MK, et al.
Alcohol use accelerates HIV disease progression. AIDS Research and Human Retroviruses
2010; 26: 511–518.
Thomson, BJ. Hepatitis C virus: the growing challenge. British Medical Bulletin
2009; 89: 153–167.
Payer, BA, et al.
The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBV. Journal of Infection
2012; 65: 142–149.
Lunge, VR, et al.
IL28B polymorphism associated with spontaneous clearance of hepatitis C infection in a Southern Brazilian HIV type 1 population. AIDS Research and Human Retroviruses
2012; 28: 215–219.
Zhang, X, et al.
HCV coinfection associated with slower disease progression in HIV-infected former plasma donors naïve to ART. PLoS One
2008; 3: e3992.